Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sysmex Corporation (6869:JPX), powered by AI.
Sysmex Corporation is currently trading at ¥1,421.5. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sysmex Corporation on Alpha Lenz.
Sysmex Corporation's P/E ratio is 16.5.
“Sysmex Corporation trades at a P/E of 16.5 (fair value) with solid ROE of 12.0%. 3Y revenue CAGR of 11.8% highlights clear growth momentum.”
Ask for details →Sysmex Corporation is a global leader in the design, development, and distribution of diagnostic testing systems and healthcare-related products. Headquartered in Kobe, Japan, Sysmex offers a comprehensive range of laboratory diagnostics equipment used in clinical settings, from hematology analyzers to urinalysis systems. These systems streamline processes in medical laboratories by automating and enhancing the accuracy and efficiency of blood and fluid testing. Widely employed across hospitals, clinics, and research institutions, Sysmex’s solutions are integral in facilitating early diagnosis and monitoring of diseases, thereby playing a crucial role in patient care and management. The company’s influence extends across various sectors, primarily impacting healthcare, biotechnology, and medical research industries. With a strong emphasis on innovation and technology, Sysmex also supports laboratory automation and information systems, making it a pivotal entity in the evolving landscape of personalized medicine. Known for its robust R&D initiatives, Sysmex contributes significantly to advancements in medical diagnostics, maintaining a reputable position within the global healthcare market through its dedication to improving health outcomes.
“Sysmex Corporation trades at a P/E of 16.5 (fair value) with solid ROE of 12.0%. 3Y revenue CAGR of 11.8% highlights clear growth momentum.”
Ask for details →Sysmex Corporation (ticker: 6869) is a company listed on JPX in the Healthcare sector (Medical Devices). It has approximately 10,533 employees. Market cap is $886.4B.
The current price is 1,421.5 with a P/E ratio of 16.52x and P/B of 1.91x.
ROE is 11.98% and operating margin is 17.85%. Annual revenue is $508.6B.